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Abstract
Positron emission tomography using 18F-ﬂuorodeoxyglucose (18F-FDG-PET) is a widely-used imaging modality
in oncology. It enables signiﬁcant functional information to to be included in analyses of anatomical data provided by
other image modalities. Although PET offers high sensitivity in detecting suspected malignant metabolism, 18F-FDG
uptake is not tumor-speciﬁc and can also be ﬁxed in surrounding healthy tissue, which may consequently be mistaken
as cancerous. PET analyses may be particularly hampered in pelvic-located cancers by the bladder’s physiological
uptake potentially obliterating the tumor uptake. In this paper, we propose a novel method for detecting 18F-FDG
bladder artifacts based on a multi-feature double-step classiﬁcation approach. Using two manually-deﬁned seeds
(tumor and bladder), the method consists of a semi-automated double-step clustering strategy that simultaneously
takes into consideration standard uptake values (SUV) on PET, Hounsﬁeld values on computed tomography (CT), and
the distance to the seeds. This method was performed on 52 PET/CT images from patients treated for locally-advanced
cervical cancer. Manual delineations of the bladder on CT images were used in order to evaluate bladder uptake
detection capability. Tumor preservation was evaluated using a manual segmentation of the tumor, with a threshold
of 42% of the maximal uptake within the tumor. Robustness was assessed by randomly selecting different initial
seeds. The classiﬁcation averages were 0.94±0.09 for sensitivity, 0.98±0.01 speciﬁcity, and 0.98±0.01 accuracy.
These results suggest this method is able to detect most 18F-FDG bladder metabolism artifacts while preserving tumor
uptake, and could thus be used as a pre-processing step for further non-parasitized PET analyses.
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1. Introduction
In the last few decades, positron emission tomogra-
phy/computed tomography (PET/CT) has been increas-
ingly employed in cancer management,enabling the si-
multaneous assessment of tumor metabolic and morpho-
logical characteristics [1][2]. Of the different techniques,
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18F-ﬂuorodeoxyglucose (18F-FDG) PET imaging is now
widely used to improve target delineation accuracy [3],
diagnostic accuracy [4][5] as well as early outcome pre-
diction in forms of cancer [6][7][8][9] that require ac-
curate delimitation and precise quantiﬁcation of tumor
metabolism. PET imaging techniques’ weak points are
low spatial resolution, partial volume effect, low contrast,
and high noise features. Also, despite PET being highly
sensitive for detecting malignant metabolism, FDG up-
take is not speciﬁc to tumor activity. 18F-FDG ﬁxation
can be observed both in healthy tissue and benign dis-
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Figure 1: Three examples of PET acquisition of locally-advanced cervi-
cal cancer, demonstrating a continuum uptake between tumor and blad-
der hyperﬁxation
eases like inﬂammation, which can thereby be mistaken
for cancer [10].
Today, numerous methodologies for 18F-FDG PET
segmentation have been proposed in the scientiﬁc liter-
ature using region-growing thresholds, edge detection,
clustering, stochastic models, and deformable models,
among other approaches [11][12][13][14]. However, de-
spite the accuracy achievable with these recent method-
ologies, most are based solely on the PET data, leading to
the possibility of including non-tumor 18F-FDG uptake in
the resulting segmentations.
When particularly considering cancers located in the
pelvic region, PET analyses may be especially hampered
by physiological uptake in the bladder, which could be a
confounder for tumor uptake [15]. Due to the bladder’s
natural ﬂow mechanics of ﬁlling and emptying, 18F-FDG
uptake can vary, thereby generating a similar PET signal
for the bladder to that of a tumor. Fig. 1 presents three
cases of locally-advanced cervical tumors with continuum
uptake within the bladder.
To avoid 18F-FDG bladder hyperﬁxation, patients are
invited to empty their bladder before commencing 18FDG
PET/CT scanning [16]. In rare cases, urinary catheters
can be used to ensure the bladder is empty for the PET
acquisition. Nevertheless, urinary catheter positioning is
known to be difﬁcult and carries a non-negligible risk of
increased irradiation damage [17].
Bladder uptake may also be suppressed by using expert
manual bladder CT delineation. However, manual delin-
eations are known to be laborious, subjective and inter-
observer dependant [11].
Current clinical practice involves manually positioning
a 3D-box encompassing the lesion to avoid adjacent struc-
tures [18][19][20][21]. Nevertheless, the 3D-box needs
to be large enough to contain the entire tumor metabolism
but also as small as possible to reduce high signals dam-
aging neighboring tissues. Evidently, these procedures
involve inter- and intra-user variability and can include
voxel artifacts depending on the proximity and shape of
the bladder.
To the best of our knowledge, no other automatic or
semi-automatic method for detecting metabolism artifacts
with the aim of improving and simplifying pelvic PET
analysis have previously been proposed. In this paper we
present a semi-automatic method for detecting 18F-FDG
bladder artifacts using a double-step clustering approach
that simultaneously exploits multimodal PET-CT data and
a priori spatial information. The k-means algorithm was
used to ensure an unsupervised clustering and low com-
putational cost. As bladder uptake is not systematically
found in these procedures, our detection method could
be considered a pre-processing step for PET imaging in
order to enable further non-parasitized tumor quantiﬁca-
tion. From this point of view, the issue we wish to ad-
dress herein is how to distinguish the bladder signal while
preserving the information arising from the tumor uptake.
This methodology was applied to real clinical data from a
standardized clinical protocol where bladder uptake was
observed in several cases.
The paper is structured as follows: Section 2 introduces
the overall framework of the study; Section 2.2 exposes
each step of the proposed methodology, followed by val-
idation based on the clinical data; Section 3 presents the
results; Section 4 presents our discussion and conclusions.
2. Material and Methods
The overall framework of our proposed methodology
for semi-automatically detecting the bladder metabolic ar-
tifacts is presented in Fig. 2. This method is divided into
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Figure 2: Overall framework of the proposed methodology for semi-automatically detecting the bladder metabolic artifacts. First, k-means cluster-
ing was performed using only PET intensity to roughly select the voxels with the highest values, likely belonging to the tumor or bladder (2.2.1).
Following manual veriﬁcation (2.2.2), an optional second step of clustering using PET/CT data and a priori spatial information was performed was
performed (2.2.3). Finally, morphological correction was applied to ensure the topological compactness of the detected region (2.2.4)
two major clustering steps. First, k-means clustering was
performed using only PET intensity to roughly select the
voxels with the highest values, likely to be those belong-
ing to the tumor or bladder (2.2.1). The largest connected
component in the resulting cluster was then considered
for the next step. Manual inspection was conducted to
verify if tumor metabolism could be visually detected in
the resulting area (2.2.2). If so, a second step of cluster-
ing was performed using PET/CT data and a priori spatial
information (2.2.3). Morphological correction was then
applied to ensure the topological compactness of the de-
tected region (2.2.4). Validation (2.3) was conducted on
a dataset of 52 PET/CT images by: i) comparing the de-
tected bladder voxel artifacts using expert manual bladder
CT delineation; ii) comparing tumor metabolism preser-
vation with respect to a segmentation on PET images us-
ing the commonly-used threshold of 42% of the maxi-
mum uptake within the tumor (T42).
The clustering algorithms and segmentations were car-
ried out using the C++ library Insight Segmentation and
Registration Toolkit (ITK).
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Figure 3: Example of pelvic region cropped according to coxal bone
structures on CT images
2.1. PET/CT dataset
We initially included 52 patients (median age: 52.44
years [32.15 - 84.62]) with locally-advanced cervical can-
cer treated at the Centre Eugene Marquis (CEM), Rennes,
France. All were treated using external beam radiation
therapy with concurrent cisplatin chemotherapy followed
by brachytherapy.
Each patient underwent an 18F-FDG PET/CT scan
prior to treatment. Patients were invited to void before
imaging. No intravenous contrast was used during the CT
acquisitions.
Each voxel from the PET scan was converted into a
standardized uptake value (SUV) for comparisons across
patients. The SUV is a standardized decay-corrected
value of 18F-FDG activity per unit volume of body weight
(MBq/kg) [22]. The full-body PET/CT images were
cropped to the pelvic region based on the coxal bone
structures visualized on CT imaging. The box boundaries
were delimited according to well-deﬁned landmarks that
could be easily reproducible. Fig. 3 depicts an example of
a cropped pelvic region.
2.2. Detection of bladder metabolic artifacts
We deﬁned bladder metabolic artifact (BMA) as areas
where the 18F-FDG bladder activity was highest and com-
parable to that originating from the tumor. We deﬁned the
calculation of BMA detection as a classiﬁcation formula
where each voxel of the PET image was assigned to one
of the three clusters of Set S:
S = {{B}, {I}, {A, T}}, (1)
where {B} and {I} refer to the voxels producing very
low and intermediate uptake values, respectively. Clus-
ter {A, T} refers to very high uptake voxels, which may
belong to either tumor {T} or non-tumor {A} classes, re-
spectively.
The BMA detection sought to accurately identify the
voxels belonging to {A}. It should be noted that {T}
does not correspond to tumor segmentation but only to
voxels with high uptake, which thus likely belong to a
tumor and should be preserved for further non-parasitized
quantitative analyses.
Due to the bladder shapes observed, we assumed that
the BMA revealed in PET imaging was a topologically
compact object. Two voxels roughly representing the
bladder and tumor barycenter were selected, denoted sb
and st, respectively.
2.2.1. SUV-based k-means clustering
In our calculations, X = {x1, x2, ..., xn} the set of n
voxels on the PET image.
In general terms, the k-means algorithm aims to parti-
tion the n voxels of X into k clusters by minimizing the
within-cluster sum of squares difference:
argmin
C
k∑
j=1
∑
xi∈cj
‖xi − μj‖2 , (2)
where C = {c1, c2, ..., ck} is the set of clusters and μj
denotes the mean of voxels in cj . With cluster set S, the
objective function becomes:
(3)
argmin
S
∑
xi ∈{B}
‖xi − μB‖2 +
∑
xi ∈{I}
‖xi − μI‖2
+
∑
xi ∈{A,T}
‖xi − μA,T ‖2 ,
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Figure 4: SUV-based k-means clustering example. (a) Original PET
exam. (b) k-means clustering result: (green) corresponds to Cluster
{A, T}, (red) to Cluster {I}, and (blue) to Cluster {B}
Fig. 4 presents an example of an SUV-based k-means
clustering with cluster set S.
As the SUV-based k-means clustering took no spatial
information into consideration, we selected the largest
connected component (lcc) of Cluster {A, T} connected
to seed sb to avoid distant regions and ensure that the re-
sulting area was only related to the BMA. The resulting
cluster was labeled {A, T}lcc.
Fig. 5a presents an example of Cluster area {A, T}lcc.
2.2.2. Manual veriﬁcation
The potential presence of tumor metabolism in Clus-
ter {A, T}lcc was determined visually. If no tumor
metabolism was present in {A, T}lcc, the cluster was de-
noted as just {A}. If tumor metabolism was visually de-
tected in {A, T}lcc, a second step of clustering using CT
information and a priori information was performed with
the intention of splitting {A} from {T}.
2.2.3. Data fusion and k-means clustering
In the second clustering step, a k-means algorithm was
applied for further classiﬁcation of Set {A, T}lcc, based
on a simultaneous exploitation of CT Hounsﬁeld units,
PET SUVs, and normalized distance maps. The dis-
tance map was built as an artifact membership probability
(AMP) as follows:
AMP (xi) = 1− d
2(xi, sb)
d2(xi, st) + d2(xi, sb)
, (4)
where d2(xi, st) and d2(xi, sb) are the squared Euclidean
distances of voxel xi from seed st and seed sb, respec-
tively.
(a) (b)
Figure 5: (a) Cluster {A, T}lcc and (b) the corresponding AMP for
each voxel in {A, T}lcc: (red) corresponds to AMP=1 and (black) to
AMP=0.
The hypothesis behind the AMP relies on the concept
that the further the voxel is from the tumor seed, the lower
the probability of it belonging to the artifacts. Similarly,
we assumed that the closer the voxel was to the bladder
seed, the higher the probability of it belonging to the blad-
der artifacts.
An example of AMP computed for each voxel in
{A, T}lcc is illustrated in Fig. 5b.
From each xi clustered in {A, T}lcc, three features
were considered: the SUV from the PET, labeled Ui; the
Hounsﬁeld unity value (HUV) from the CT, labeled Hi;
the AMP, labeled Pi. The SUVs and HUVs were normal-
ized between 0 and 1. We denoted V{A,T}lcc = {vi} the
group of vector vi = (Ui Hi Pi)T .
Fig. 6a represents an example of V{A,T}lcc projected
in the tri-parametric space [SUV HUV AMP ].
Each vi was assigned a label stating if it belonged to
cluster {T} or {A}, following the objective function be-
low:
argmin
{A,T}lcc
∑
vi∈{T}
‖vi − μT ‖2+
∑
vi∈{A}
‖vi − μA‖2 , (5)
Fig. 6b represents an example of the k-means clustering
in the tri-parametric space [SUV,HUV,AMP ].
In accordance with the compactness hypothesis on the
BMA shape, the largest connected component of the clus-
ter connected with seed sb was selected to be {A}.
2.2.4. Area correction
Topological transformations, namely closing and open-
ing were applied to ensure the compactness of the result-
ing area formed by {A}. The resulting corrected area was
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Figure 6: Data fusion and k-means clustering example. (a) voxels
belonging to {A, T}lcc placed in the tri-parametric clustering space
[SUV HUV TMP ] : SUV value (SUV), Hounsﬁeld unity value
(HUV), and the artifact membership probability (AMP). (b) k-means
clustering result: cluster {A} in black and cluster {T} in green. (c)
Cluster {A, T}lcc and (d) the resulting cluster {A}.
labeled BMA. Fig. 7 presents an example of an area cor-
rection for obtaining the BMA.
2.3. Validation
2.3.1. Measures of performance of BMA detection
We measured the performance of the BMA detection
carried out by the proposed algorithm in two phases. First,
we considered solely an expert manual bladder CT de-
lineation as ground-truth (true-positives) and computed
the sensitivity, speciﬁcity and accuracy of the BMA de-
tection. Secondly, we considered a tumor segmenta-
tion mask as the background (true-negatives) and com-
puted the related sensitivity, speciﬁcity and accuracy in
order to assess the algorithm’s tumor preservation capa-
bility. The bladder was manually segmented by an ex-
pert on each CT image using the Phillips Pinnacle3 Ver-
sion 8.0m treatment planning software. The CT images
were then linearly down-sampled to the PET resolution
so that each PET voxel corresponded to only one voxel
of the CT, and likewise for the bladder delineations. Tu-
mor metabolic activities were segmented on PET images
(a) (b)
Figure 7: Area correction example. (a) Cluster {A}. (b) Bladder
metabolic artifact (BMA) following area correction.
by region-growing using a threshold of 42% of the max-
imum uptake within the tumor (T42). Residual bladder
uptake in the T42 segmentation mask was suppressed by
the corresponding manual bladder CT delineation.
The voxels outside the bladder mask were considered
true negatives (TN), whereas the voxels within the bladder
mask were the true positives (TP). The number of voxels
originally located in the bladder and not detected as arti-
facts were labeled false negatives (FN). Lastly, the num-
ber of voxels originally localted outside the bladder mask
and detected as artifacts were labeled false positives (FP).
In parallel, the detection was evaluated a second time
using the T42 segmentation mask. The number of voxels
detected as artifacts yet originally located inside the T42
mask were this time considered false positives (FPT42),
whereas the number of voxels in the T42 mask that
were not detected as artifacts were labeled true negatives
(TNT42).
Fig. 8 illustrates the PET and CT delineations used to
evaluate the detection of bladder metabolic artifacts per-
formed by the proposed methodology.
For the sake of clarity, we describe below how we
computed the measures of performance of the detection
method for each PET image, namely sensitivity (SEN),
speciﬁcities (SPE and SPET42) and accuracies (ACC and
ACCT42) :
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Figure 8: PET and CT delineations used for evaluating the BMA detec-
tion method. Bladder Mask: Expert manual bladder CT delineations lin-
early down-sampled to the PET resolution. Tumor Segmentation (T42):
Metabolic activities segmented on PET images by region-growing using
a threshold of 42% of the maximum uptake within the tumor
SEN =
TP
TP + FN
,
SPE =
TN
TN + FP
,
ACC =
TP + TN
TP + TN + FP + FN
,
SPET42 =
TNT42
TNT42 + FPT42
,
ACCT42 =
TP + TNT42
TP + TNT42 + FPT42 + FN
.
(6)
2.3.2. Reproducibility evaluation
Reproducibility was assessed by randomly selecting 30
different seed pairs (sb and st) within a 2×2×2-cm region
around the initial manually-selected seeds. Thus, 30 dif-
ferent BMA detections were performed for each image.
3. Results
In this study, 47 out of 52 PET images presented tu-
mor uptake in region {A, T}lcc and were considered in
the second clustering step. Fig. 9 presents four examples
of BMA detection using the proposed method.
The values attesting to the proposed detection method’s
performance (SEN, SPE, SPET42 ACC and ACCT42) for
all PET images of our dataset have been presented using
a boxplot representation in Fig. 10. For all 52 BMA de-
tections evaluated, the averaged results were 0.94 ± 0.09
SEN, 0.98 ± 0.01 SPE and 0.98 ± 0.01 ACC. For the
T42 segmentation, the averaged results were 0.97± 0.05
SPET42 and 0.94± 0.08 ACCT42.
In the 30 seed pairs randomly selected for each image,
a total of 1,560 BMA detections (52 × 30) were obtained
to enable assessment of the method’s reproducibility.
For these BMA detections, the average SEN, SPE and
ACC were 0.91± 0.13, 0.98± 0.02 and 0.98± 0.02, re-
spectively. For the T42 mask, the average SEN values
were the same, and the SPET42 and ACCT42 averages
were 0.96± 0.07 and 0.92± 0.12, respectively.
The overall robustness of the results for the whole co-
hort is depicted in Fig. 11. This demonstrates that for
most of the seeds locations, the same segmentation was
obtained. However, if the seed was located outside the
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Figure 9: Example of BMA detection results for four patients. (a)-(d) Original PET exams. (e)-(h) 2.2.1 SUV-based k-means clustering results.
(i)-(l) Clusters {A, T}lcc. (m)-(o) cluster {A} following 2.2.3 data fusion and k-means clustering. (p)-(s) BMA regions following 2.2.4 area
correction. (t)-(w) PET image with BMA highlighted
bladder, the regions could naturally be erroneously de-
tected. In some cases, SEN=0 due to the random place-
ment of seed sb outside the bladder.
4. Discussion & Conclusion
In PET images, 18F-FDG ﬁxation can be observed in
healthy tissue and benign disease, which are consequently
mistaken for cancer [10]. PET analysis can be particularly
hampered in cancers involving the pelvic region by the
physiological uptake of the bladder, which can obliterate
the tumor uptake of lesions located in this area [15].
In this paper we propose a semi-automatic method
to detect 18F-FDG bladder artifacts in PET imaging of
pelvic cancer using a k-means clustering approach by
combining PET and CT information.
Artifact detection was considered to be a means of pre-
processing PET voxel classiﬁcation, and particular atten-
tion was paid to the preservation of tumor metabolism to
enable further non-parasitized PET analyses.
The problem of detection was tackled by a two-step
clustering relying on two assumptions. 1) That only the
voxels with high intensity would hamper the analyses of
tumor metabolism in PET imaging. To select these vox-
els, we applied an SUV-based clustering algorithm with
three classes (low, intermediate, and high intensities). 2)
That the bladder artifacts would be the sole artifacts de-
tected among the previously-selected voxels. Therefore,
the high-intensity voxels could belong to either artifacts or
tumors. A second clustering step using CT and a priori in-
formation was then performed to separate voxels belong-
ing to the artifacts from those belonging to tumor activity.
As the number of classes was ﬁxed, we used the k-means
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Figure 11: Overall results for the 52 patients for different seed locations. SEN, SPE, and ACC values correspond to the evaluation of the BMA
detection method only considering bladder mask. SPET42 and ACCT42 correspond to the evaluation of BMA detection performance using both
bladder mask and T42 mask
algorithm to ensure unsupervised clustering and low com-
putational cost. Nonetheless, for one given patient, we
visually decided if the second classiﬁcation step was nec-
essary. Numerous other clustering algorithms have also
been published in the literature [23]. For instance, the
afﬁnity propagation algorithm [24] or the density-based
spatial clustering [25] could be used to automatically de-
termine the number of clusters needed and, therefore, de-
tect bladder artifacts in a one-step clustering process. Fur-
ther investigation will be required to evaluate the use of
such algorithms for the current challenge of reducing user
dependency by automating the decision procedure.
Our proposed bladder artifact detection algorithm was
tested on 52 PET/CT images of patients with locally-
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Figure 10: Values of the proposed algorithm’s performance for the 52
PET images. SEN, SPE, and ACC corresponding to the evaluation of
the BMA detection method, only considering bladder mask. SPET42
and ACCT42 correspond to the evaluation of the BMA detection method
considering both bladder mask and T42 mask.
advanced cervical cancer. We believe that the cancer’s
localization was relevant to our detection problem, as the
bladder often presents an uptake continuum with the cer-
vical tumor. However, in order to be applied to different
pelvic cancer localizations, the algorithm would need to
be adapted accordingly. To achieve this, further inves-
tigations should be carried out to evaluate the proposed
method in other cancer localizations.
On our dataset of 52 PET images, only ﬁve were con-
sidered well-clustered following the ﬁrst k-means clus-
tering. This proves the interest of exploiting multimodal
PET-CT data combined with a priori spatial information
to distinguish bladder artifacts from tumor uptake.
We evaluated this proposed method ﬁrstly by compar-
ing the detected bladder voxel artifacts with expert man-
ual bladder CT delineation. Our results demonstrated
the ability of the proposed method to classify voxels
belonging to the bladder, with good average sensitiv-
ity, speciﬁcity, and accuracy (0.94±0.09, 0.98±0.01, and
0.98±0.01, respectively). We observed a lower sensitivity
corresponding to a general underestimation of the bladder
artifacts, which enabled the preservation of tumor activ-
ity. It should be noted that the 18F-FDG uptake of the
bladder did not systematically correspond to the bladder’s
anatomical shape. The bladder actually ﬁlls during PET
image acquisition, as it takes several minutes, while CT
data is acquired in a matter of seconds. Manual CT delin-
eations used for evaluation are thus not strictly represen-
tative of the bladder’s real metabolism.
The method was further evaluated using a threshold
method often used in clinical practice (T42) as a region
to spare. Speciﬁcity and accuracy were recomputed ac-
cording to the T42 mask. It should be noted that T42
mask was not considered here as a ground truth of tumor
metabolism, but rather as a reference enabling evaluation
of the method’s tumor-preservation capability. With its
average speciﬁcity (SPET42) of 0.97±0.05 and accuracy
(ACCT42) of 0.94±0.08, it demonstrated good conserva-
tion of tumor metabolism.
In order to initialize the second step of clustering to
separate bladder voxels from tumor voxels, an artifact
membership probability (AMP), derived from the squared
Euclidean distance of the a priori tumor and bladder lo-
cations, was computed. We assumed, however, that the
seeds were positioned near the barycenter of the blad-
der and tumor metabolism, positions that can lead to re-
sult variability. The robustness of the proposed algorithm
was assessed by randomly selecting 30 different initial
seeds for each of the 52 PET images. The overall aver-
ages indicate that the method is globally precise and ro-
bust for the seed initialization, achieving 0.91±0.13 SEN,
0.98±0.02 SPE, 0.98±0.02 ACC, 0.96±0.07 SPET42,
and 0.92±0.12 ACCT42. To reduce the variability, an al-
ternative method that could be employed in future studies
would be to include the possibility for users to select more
seed points, thus incorporating more a priori information.
In conclusion, this proposed semi-automated method
for detecting bladder metabolic artifacts on PET images
of the pelvic region offers good preservation of tumor
metabolism. This method can be used as a preprocessing
step for further non-parasitized analyses.
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